Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141,940 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.
Kim YK, Vidor E, Kim HM, Shin SM, Lee KY, Cha SH, Ma SH, Kim DH, Lee J, Park SE, Lee H, Kim JD, Kim KH, Kim KH, Kim JH; A3L31 Study Group. Kim YK, et al. Among authors: lee h, lee j, lee ky. Vaccine. 2017 Jul 13;35(32):4022-4028. doi: 10.1016/j.vaccine.2017.05.062. Epub 2017 Jun 16. Vaccine. 2017. PMID: 28629923 Clinical Trial. No abstract available.
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A. Kim DS, et al. Among authors: lee j. Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6. Hum Vaccin Immunother. 2014. PMID: 25483480 Free PMC article. Clinical Trial.
The Immunogenicity and Safety of a Combined DTaP-IPV//Hib Vaccine Compared with Individual DTaP-IPV and Hib (PRP~T) Vaccines: a Randomized Clinical Trial in South Korean Infants.
Kang JH, Lee HJ, Kim KH, Oh SH, Cha SH, Lee J, Kim NH, Eun BW, Kim CH, Hong YJ, Kim HH, Lee KY, Kim YJ, Cho EY, Kim HS, Guitton F, Ortiz E. Kang JH, et al. Among authors: lee j, lee ky, lee hj. J Korean Med Sci. 2016 Sep;31(9):1383-91. doi: 10.3346/jkms.2016.31.9.1383. J Korean Med Sci. 2016. PMID: 27510380 Free PMC article. Clinical Trial.
Safety and Immunogenicity of an Egg-Cultivated Quadrivalent Inactivated Split-virion Influenza Vaccine (GC3110A) in Healthy Korean Children: a Randomized, Double-blinded, Active-controlled Phase III Study.
Lee J, Lee KY, Kim JH, Kim CS, Eun BW, Kim HM, Kim DH, Hong YJ, Choi YY, Jo DS, Ma SH, Kang JH. Lee J, et al. Among authors: lee ky. J Korean Med Sci. 2018 Mar 26;33(13):e100. doi: 10.3346/jkms.2018.33.e100. J Korean Med Sci. 2018. PMID: 29573247 Free PMC article. Clinical Trial.
Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
Choi UY, Kim KH, Lee J, Eun BW, Kim DH, Ma SH, Kim CS, Lapphra K, Tangsathapornpong A, Kosalaraksa P, Oberdorfer P, Kim HM, Shin SM, Kang JH. Choi UY, et al. Among authors: lee j. Vaccine. 2021 Mar 19;39(12):1758-1764. doi: 10.1016/j.vaccine.2021.02.013. Epub 2021 Feb 21. Vaccine. 2021. PMID: 33627245 Clinical Trial.
Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
Choi UY, Kim KH, Lee KY, Kim JH, Kim CS, Eun BW, Kim HM, Kim DH, Song SE, Jo DS, Lee J, Ma SH, Kim KN, Kang JH. Choi UY, et al. Among authors: lee j, lee ky. Vaccine. 2021 Apr 8;39(15):2103-2109. doi: 10.1016/j.vaccine.2021.03.005. Epub 2021 Mar 16. Vaccine. 2021. PMID: 33736920 Clinical Trial.
141,940 results
You have reached the last available page of results. Please see the User Guide for more information.